While USP 797 focuses on protecting patients from contamination in compounded sterile preparations, USP General Chapter 800 addresses a distinct, complementary concern: protecting the healthcare personnel who handle hazardous drugs — primarily chemotherapy agents and certain other medications with documented occupational health risk — from the exposure risks these specific drugs present.
The NIOSH Hazardous Drug List Defines the Standard's Actual Scope
USP 800 requirements apply specifically to drugs identified on the NIOSH (National Institute for Occupational Safety and Health) hazardous drug list, which is periodically updated and categorizes drugs based on documented carcinogenicity, reproductive toxicity, or organ toxicity concerns — facilities must actively track which medications in their formulary appear on this list and apply USP 800 requirements specifically to those products, rather than assuming standard pharmacy handling precautions automatically satisfy this distinct, more rigorous standard.
Closed-System Drug-Transfer Devices Address a Specific Exposure Pathway
USP 800 requires closed-system drug-transfer devices for handling many hazardous drugs, engineering controls specifically designed to prevent the escape of hazardous drug or vapor concentrations into the surrounding environment during preparation and administration — this requirement reflects documented evidence that healthcare workers handling hazardous drugs without such controls show measurable environmental and biological markers of exposure, even when following otherwise careful standard handling technique.
Personal Protective Equipment Requirements Are More Extensive Than Standard Compounding PPE
USP 800 specifies particular PPE requirements for hazardous drug handling — chemotherapy-rated gloves meeting specific testing standards, gowns with demonstrated impermeability to hazardous drugs, and, for certain higher-risk activities, respiratory protection — that exceed the standard PPE used for routine, non-hazardous sterile compounding, reflecting the genuinely elevated exposure risk these specific medications present.
Facility Design Requires Negative Pressure and Dedicated Space
Hazardous drug compounding requires a dedicated, negative-pressure room design specifically intended to prevent hazardous drug contamination from migrating into adjacent pharmacy or clinical areas — this facility design requirement is distinct from and, in some respects, more stringent than general sterile compounding facility requirements, reflecting the additional worker safety dimension USP 800 specifically addresses beyond product sterility alone.
Surface Wipe Sampling Provides Objective Evidence of Contamination Control
Many facilities implementing USP 800 conduct periodic surface wipe sampling for hazardous drug residue in compounding areas and, in some cases, adjacent clinical spaces, providing objective evidence of whether containment controls are actually preventing environmental contamination as intended — this monitoring parallels the environmental monitoring philosophy behind USP 797 but specifically targets hazardous drug residue rather than microbiological contamination.
Reproductive Health Considerations Receive Specific Attention
Given the reproductive toxicity concerns associated with many hazardous drugs, USP 800 compliance programs typically include specific policies addressing personnel who are pregnant, breastfeeding, or actively trying to conceive, offering informed options regarding hazardous drug handling duties — this reflects the standard's underlying occupational health framing, treating hazardous drug exposure as a genuine workplace safety issue warranting the same kind of accommodation consideration given to other recognized occupational reproductive health risks.
Conclusion
USP 800 addresses healthcare worker protection from hazardous drug exposure through closed-system transfer devices, specific PPE requirements, dedicated negative-pressure facility design, and ongoing contamination monitoring — a genuinely distinct focus from sterile compounding's patient-safety orientation. Facilities handling hazardous drugs depend on properly rated protective equipment and pharmacy supplies to support this worker safety standard.
